The Ministry of Health (MoH) alerted members of the public of a health product found to be adulterated with undeclared, potent western medicines tested by the Laboratory of Pharmacy Section, Department of Scientific Services, MoH.
The affected health product is Evo-7 Japan Sachet, manufactured by Evo Freedom International Sdn Bhd, found adulterated with Tadalafil.
The adulterant can cause adverse effects that are potentially hazardous to the people using them.
Tadalafil and Sildenafil are drugs used to treat male impotency and can only be prescribed by a qualified doctor or physician. Among their side effects include nausea, vomiting, flushing and dizziness.
In severe cases, they can also result in abnormal increase in heart rate, sudden loss of hearing and seizures.
The MoH has not issued any approval for the importation for the sale of this product. Following these findings, the product is not allowed to be imported and sold in Brunei Darussalam.
Members of the public who have purchased or used this product are advised to stop using it immediately.
They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.
Members of the public involved in the retail of the product, including online retail are reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act.
The penalty for contravening these regulations upon conviction, is a fine of BND8,000 or six months’ imprisonment.
If a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of BND16,000 and 12 months’ imprisonment.
The ministry called upon the public for cooperation to report to the Compliance and Licensing Section if any of these products are still found in the Brunei market.
The public can contact the Compliance and Licensing Section at 2393298, extension 208; send an e-mail to [email protected]; go directly to the first floor, Compliance and Licensing Section, Department of Pharmaceutical Services’ Building, Kampong Madaras, Mukim Gadong ‘A’; or call Darussalam line 123.